M. Mandelbaum

Randomised controlled trial to evaluate the effectiveness of using the RD-1-based C-Tb skin test as a replacement for blood-based interferon-γ release assay for detection of, and initiation of preventive treatment for, tuberculosis infection: RID-TB:Dx study protocol

R. Horne, P. Whiting, A. Crook, 2021, BMJ Open.

IMPACT study on intervening with a manualised package to achieve treatment adherence in people with tuberculosis: protocol paper for a mixed-methods study, including a pilot randomised controlled trial

R. Horne, A. Copas, A. Story, 2019, BMJ Open.

“You have to change your whole life”: A qualitative study of the dynamics of treatment adherence among adults with tuberculosis in the United Kingdom

R. Horne, B. Marshall, Ananna Rahman, 2021, Journal of clinical tuberculosis and other mycobacterial diseases.

Guidance for programmatic management of latent tuberculosis infection in the European Union/European Economic Area

S. D. de Vlas, W. Haas, A. Matteelli, 2019, European Respiratory Journal.

Evaluating the effect of short-course rifapentine-based regimens with or without enhanced behaviour-targeted treatment support on adherence and completion of treatment for latent tuberculosis infection among adults in the UK (RID-TB: Treat): protocol for an open-label, multicentre, randomised contro

R. Horne, A. Crook, K. Sanders, 2022, BMJ Open.